Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794170 · ClinicalTrials.gov registry record · NA
Interactive Study to Increase Glaucoma Adherence to Treatment
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 312
- Enrollment target
NCT00794170 is a NA study that has completed, run by Emory University. The registered enrollment target is 312 participants.
The verdict
NCT00794170, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
Study Summary
Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group intervention.
Interventions
- BEHAVIORAL Telephone and Print based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00794170
The ClinicalTrials.gov registry entry for NCT00794170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telephone and Print based intervention is the first listed.
NCT00794170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00794170 about?
NCT00794170 is a clinical study titled "Interactive Study to Increase Glaucoma Adherence to Treatment". Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group i...
What is the current status of trial NCT00794170?
This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2008-08. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00794170?
The interventions under investigation include: Telephone and Print based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00794170?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.